(Q42633478)

4 November 2017

title

Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics (English)

1 reference

4 November 2017

1 reference

1 reference

Wong SL

1

1 reference

4 November 2017

Cavanaugh J

2

1 reference

4 November 2017

Shi H

3

1 reference

4 November 2017

Awni WM

4

1 reference

4 November 2017

Granneman GR

5

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

Clinical Pharmacology & Therapeutics

4 November 2017

published in

1 reference

4 November 2017

volume

60

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

48-53

1 reference

Valproate in the treatment of acute mania. A placebo-controlled study

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Migraine prophylaxis. A comparison of propranolol and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Sodium valproate acutely inhibits lamotrigine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Quantification of amitriptyline, nortriptyline, and 10-hydroxy metabolite isomers in plasma by capillary gas chromatography with nitrogen-sensitive detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Influence of First-Pass Effect on Availability of Drugs on Oral Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Enantioselective amitriptyline metabolism in patients phenotyped for two cytochrome P450 isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Amitriptyline disposition in young and elderly normal men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Interindividual differences in amitriptyline demethylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Glucuronidation of amitriptyline in man in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Lorazepam-valproate interaction: studies in normal subjects and isolated perfused rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Inhibitory studies of mexiletine and dextromethorphan oxidation in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

Amitriptyline pharmacokinetics and clinical response: II. Metabolic polymorphism assessed by hydroxylation of debrisoquine and mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990166-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(96)90166-6

1 reference

4 November 2017

1 reference